Lilly’s Affordable Zepbound Vials: A Game Changer
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
- Latest
- Trending
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Teladoc Health's revenue grew by 8% to $2.6 billion in 2023, with a gross margin of 70.8%. On the other ...
Phase 1 biotech Boundless Bio raised $100 million at a $396 million market cap. Two IPOs are scheduled for the ...
SpaceX seeks FCC approval to bring its second-generation Starlink satellites closer to Earth, aiming to improve internet speeds. CEO Elon ...
The Dale County Board of Education has received a $741,190 grant from the USDA to boost health technology and telehealth ...
The U.S. opioid crisis necessitates a strategic approach to allocating settlement funds for health IT infrastructure. Three recommendations include integrating ...
Discover how CareCloud is revolutionizing healthcare with its smart technology solutions. Streamline administrative tasks, improve efficiency, and enhance patient care ...
Economic Overview of Alabama: Opportunities and Challenges in Zip Code {Zip Code} Analyzing Healthcare Access in Alaska: A Deep Dive ...
The Consumer Electronics Show, better known as CES, is back in Las Vegas with more than 3,500 companies from around ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.